CASE Op-Ed: Transparency Is Key to Lower Medicare Part D Costs
http://bit.ly/2EsfFSE Matthew Kandrach, CASE President Government programs don’t have a great track record of coming in under budget, but Medicare...
http://bit.ly/2EsfFSE Matthew Kandrach, CASE President Government programs don’t have a great track record of coming in under budget, but Medicare...
For most Americans, being hospitalized is a rare and frightening event. Trips to the emergency room, or even for an...
Consumer Action for a Strong Economy (CASE) — the nation’s preeminent free-market consumer advocacy organization – today issued the following...
Read full article here: by CASE President Matthew Kandrach Pharmacy Benefit Managers (PBMs), the goliath health insurance middle-men wedged between...
Opinion: September 11, 2017 Health care providers have been consolidating at an increasing rate in recent years. Nowhere is this more...
After 6 years and 6 fruitless attempts to repeal Obamacare in its entirety, repeal is finally within sight of Congress....
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers